### 60873 Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices

accommodate all requests, the ASC may refuse attendance on that reasonable basis. The use of any video or audio tape recording device, photographing device, or any other electronic or mechanical device designed for similar purposes is prohibited at ASC meetings.

Dated: September 26, 2013. James R. Park,
Executive Director. [FR Doc. 2013–23985 Filed 10–1–13; 8:45 am]

**BILLING CODE 6700–01–P**

**FEDERAL FINANCIAL INSTITUTIONS EXAMINATION COUNCIL** 
**[Docket No. AS13–23]**
**Appraisal Subcommittee Meeting**

**AGENCY :**  Appraisal Subcommittee of the Federal Financial Institutions Examination Council.

**ACTION :**  Notice of meeting.

**SUMMARY :**  In accordance with Section 1104(b) of Title XI of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989, as amended, notice is hereby given that the Appraisal Subcommittee (ASC) will meet in closed session:

**DATES :**  October 9, 2013.

**ADDRESSES :**  400 7th Street SW., Washington, DC 20024.

**SUPPLEMENTARY INFORMATION :**  Location: OCC—400 7th Street SW.,

Washington, DC 20024 Date: October 9, 2013 Time: Immediately following the ASC

open session Status: Closed

Matters To Be Considered September 11, 2013 minutes—Closed

Session Preliminary discussion of State

Compliance Reviews Dated: September 26, 2013. James R. Park,
Executive Director. [FR Doc. 2013–23986 Filed 10–1–13; 8:45 am]

**BILLING CODE 6700–01–P**

**FEDERAL RESERVE SYSTEM**
**Change in Bank Control Notices; Acquisitions of Shares of a Bank or**  **Bank Holding Company**

The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).

The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than October 16, 2013.

A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001:

1. Glory Burns, Fort Collins, Colorado, Robin Isham, Templeton, California, Andrea Voss, Chadron, Nebraska, Julie Jennings, Lone Tree, Colorado, and R. Will Isham, Gordon, Nebraska, individually and as trustees of the E. Joy Isham Irrevocable Trust, and the RWI Marital Deduction Testamentary Trust, both of Gordon, Nebraska, all as members of the Isham Family Group, to retain voting shares of Isham Management Company, and thereby indirectly retain voting shares of The First National Bank of Gordon, both in Gordon, Nebraska.

Board of Governors of the Federal Reserve System, September 26, 2013. Margaret McCloskey Shanks, Deputy Secretary of the Board.
[FR Doc. 2013–23936 Filed 10–1–13; 8:45 am]

**BILLING CODE 6210–01–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 
**Office of the Secretary**
**Findings of Research Misconduct**

**AGENCY :**  Office of the Secretary, HHS.

**ACTION :**  Notice.

**SUMMARY :**  Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following

case:

Nitin Aggarwal, Ph.D., Medical College of Wisconsin and University of Wisconsin-Madison: Based on the reports of the investigations conducted by the Medical College of Wisconsin (MCW) and the University of Wisconsin-Madison (UW) and additional analysis conducted by the ORI in its oversight review, ORI found that Dr. Nitin Aggarwal, former Graduate Student, MCW, and former Assistant Scientist, UW, engaged in research misconduct in research supported by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), grants R01 HL37981, R01 HL54075, and R01 HL57414.

ORI found that that the Respondent engaged in research misconduct byfalsifying and/or fabricating PHSsupported data in six (6) figures that were included in the following two (2) publications, one (1) grant application to the American Heart Association (AHA), one (1) grant application to NIH, and the Respondent’s Ph.D. thesis:

• Aggarwal, N.T., Pfister, S.L., & Campbell, W.B. ‘‘Hypercholesterolemia Enhances 15-Lipoxygenase MediatedVasorelaxation and AcetylcholineInduced Hypotension.’’ Arteriosclerosis, Thrombosis, and Vascular Biology 28:2209–2215, 2008 (hereafter the

‘‘ATVB paper’’).

• Aggarwal, N.T., Pfister, S.L., Gauthier, K.M., Chawengsub, Y., Baker, J.E., & Campbell, W.B. ‘‘Chronic hypoxia enhances 15-lipoxygenase-mediated vasorelaxation in rabbit arteries.’’ American Journal of Physiology—Heart Circulation Physiology 296:H678–H688, 2008 (hereafter the ‘‘AJP paper’’).

• Aggarwal, N.T., Principal Investigator (P.I.), National Scientist Development grant application to the American Heart Association No. 11SDG7650072, ‘‘Sulfonylurea rReceptor-2 splice variant and mitochondrial mechanisms for cardioprotection and arrhythmia’’ (hereafter the ‘‘AHA grant application’’).

• K99 HL113518–01, ‘‘Mitochondrial ATP-sensitive K-channels and pharmacological approaches for cardioprotection,’’ Aggarwal, Nitin, Ph.D., P.I.

• Aggarwal, N.T. ‘‘Endothelial 15- lipoxygenase regulates vasorelaxation and blood pressure in rabbits in normal and pathological condictions.’’ A Dissertation Submitted to the Faculty of the Graduate School of Biomedical Science of the Medical College of Wisconsin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy, Milwaukee, Wisconsin, 2008 (hereafter the ‘‘thesis’’).

Specifically, ORI found that Respondent engaged in research misconduct by falsifying Western blot loading control data by inverting, duplicating, and cropping source blot films and/or using films from unrelated experiments to construct five (5) false Western blot figures. In the absence of valid blot images, Respondent falsified and/or fabricated the corresponding quantitative data for summary bar graphs and the data statistics in related text. Respondent admitted to falsely reporting the number of mice reported for an experiment reported in Figure 4